PubRank

Sonja A Rasmussen

Author PubWeight™ 166.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009 12.32
2 Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 2010 5.94
3 Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics 2005 4.91
4 Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 2011 4.14
5 Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 2007 3.79
6 Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet 2002 3.35
7 The contribution of preterm birth to infant mortality rates in the United States. Pediatrics 2006 3.01
8 A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 2003 2.88
9 Emerging infections and pregnancy. Emerg Infect Dis 2006 2.75
10 Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004. Pediatrics 2006 2.53
11 Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med 2007 2.43
12 Maternal obesity and risk for birth defects. Pediatrics 2003 2.33
13 What obstetrician-gynecologists should know about Ebola: a perspective from the Centers for Disease Control and Prevention. Obstet Gynecol 2014 2.04
14 Maternal nutrient intakes and risk of orofacial clefts. Epidemiology 2006 1.70
15 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol 2011 1.69
16 Association between pregnancy intention and reproductive-health related behaviors before and after pregnancy recognition, National Birth Defects Prevention Study, 1997-2002. Matern Child Health J 2009 1.68
17 Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology 2007 1.67
18 Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol 2011 1.66
19 Prescription medication borrowing and sharing among women of reproductive age. J Womens Health (Larchmt) 2008 1.64
20 A population-based study of craniosynostosis in metropolitan Atlanta, 1989-2003. Am J Med Genet A 2008 1.63
21 Are children born after assisted reproductive technology at increased risk for adverse health outcomes? Obstet Gynecol 2004 1.61
22 Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol 2012 1.56
23 Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep 2016 1.56
24 Orofacial clefts in the National Birth Defects Prevention Study, 1997-2004. Am J Med Genet A 2009 1.55
25 Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep 2004 1.52
26 Health concerns of women and infants in times of natural disasters: lessons learned from Hurricane Katrina. Matern Child Health J 2007 1.48
27 Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol 2009 1.38
28 Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 2007 1.34
29 Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection - United States, 2016. MMWR Morb Mortal Wkly Rep 2016 1.29
30 Patterns of antidepressant medication use among pregnant women in a United States population. J Clin Pharmacol 2010 1.28
31 The contribution of chromosomal abnormalities to congenital heart defects: a population-based study. Pediatr Cardiol 2011 1.24
32 Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep 2016 1.21
33 Maternal attitudes toward DNA collection for gene-environment studies: a qualitative research study. Am J Med Genet A 2009 1.18
34 Priorities for future public health research in orofacial clefts. Cleft Palate Craniofac J 2007 1.18
35 Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature. Am J Med Genet A 2009 1.17
36 Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn. N Engl J Med 2006 1.16
37 Maternal periconceptional alcohol consumption and risk of orofacial clefts. Am J Epidemiol 2007 1.13
38 Correlates of seasonal influenza vaccine coverage among pregnant women in Georgia and Rhode Island. Obstet Gynecol 2010 1.13
39 Lymphocytic choriomeningitis virus: an emerging obstetric pathogen? Am J Obstet Gynecol 2006 1.11
40 Prophylaxis and treatment of pregnant women for emerging infections and bioterrorism emergencies. Emerg Infect Dis 2006 1.11
41 Medication use during pregnancy and lactation: an urgent call for public health action. J Womens Health (Larchmt) 2005 1.10
42 Zika Virus Infection Among U.S. Pregnant Travelers - August 2015-February 2016. MMWR Morb Mortal Wkly Rep 2016 1.08
43 Obstetrician/gynecologists' knowledge, attitudes, and practices regarding prevention of infections in pregnancy. J Womens Health (Larchmt) 2009 1.03
44 Prevalence of self-reported infection during pregnancy among control mothers in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 2009 1.02
45 Population-based study of congenital diaphragmatic hernia: risk factors and survival in Metropolitan Atlanta, 1968-1999. Birth Defects Res A Clin Mol Teratol 2003 1.02
46 Varicella vaccine exposure during pregnancy: data from 10 Years of the pregnancy registry. J Infect Dis 2008 1.01
47 Risk factors for non-syndromic holoprosencephaly in the National Birth Defects Prevention Study. Am J Med Genet C Semin Med Genet 2010 1.01
48 Fetal constraint as a potential risk factor for craniosynostosis. Am J Med Genet A 2010 1.00
49 Health of children 3 to 17 years of age with Down syndrome in the 1997-2005 national health interview survey. Pediatrics 2009 0.99
50 Current estimate of Down Syndrome population prevalence in the United States. J Pediatr 2013 0.98
51 Prepregnancy obesity: a complex risk factor for selected birth defects. Birth Defects Res A Clin Mol Teratol 2010 0.98
52 Seasonal influenza vaccine coverage among pregnant women: pregnancy risk assessment monitoring system. J Womens Health (Larchmt) 2011 0.97
53 Maternal use of bupropion and risk for congenital heart defects. Am J Obstet Gynecol 2010 0.96
54 Pregnancy termination following prenatal diagnosis of anencephaly or spina bifida: a systematic review of the literature. Birth Defects Res A Clin Mol Teratol 2012 0.96
55 Risk of birth defects among children conceived with assisted reproductive technology: providing an epidemiologic context to the data. Fertil Steril 2005 0.96
56 Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007. Birth Defects Res A Clin Mol Teratol 2012 0.96
57 Examining the evidence for vascular pathogenesis of selected birth defects. Am J Med Genet A 2010 0.95
58 Knowledge and attitudes of adults towards smoking in pregnancy: results from the HealthStyles© 2008 survey. Matern Child Health J 2015 0.95
59 Zika Virus and Pregnancy: What Obstetric Health Care Providers Need to Know. Obstet Gynecol 2016 0.94
60 Maternal exposure to statins and risk for birth defects: a case-series approach. Am J Med Genet A 2008 0.93
61 Association between maternal age and birth defects of unknown etiology: United States, 1997-2007. Birth Defects Res A Clin Mol Teratol 2012 0.93
62 Qualitative assessment of study materials and communication strategies used in studies that include DNA collection. Am J Med Genet A 2011 0.92
63 Associations between periconceptional alcohol consumption and craniosynostosis, omphalocele, and gastroschisis. Birth Defects Res A Clin Mol Teratol 2011 0.92
64 Updated preparedness and response framework for influenza pandemics. MMWR Recomm Rep 2014 0.92
65 Effect of specimen storage conditions on newborn dried blood spots used to assess Toxoplasma gondii immunoglobulin M (IgM). Clin Chim Acta 2010 0.92
66 Nutrient intakes in women and congenital diaphragmatic hernia in their offspring. Birth Defects Res A Clin Mol Teratol 2008 0.92
67 Update: Interim Guidelines for Health Care Providers Caring for Infants and Children with Possible Zika Virus Infection - United States, February 2016. MMWR Morb Mortal Wkly Rep 2016 0.92
68 Descriptive epidemiology of infantile cataracts in metropolitan Atlanta, GA, 1968-1998. Arch Pediatr Adolesc Med 2003 0.92
69 Cancer in children with nonchromosomal birth defects. J Pediatr 2012 0.92
70 Evaluation of mailed pediatric buccal cytobrushes for use in a case-control study of birth defects. Birth Defects Res A Clin Mol Teratol 2011 0.91
71 Update: Interim Guidance for the Evaluation and Management of Infants with Possible Congenital Zika Virus Infection - United States, August 2016. MMWR Morb Mortal Wkly Rep 2016 0.90
72 Genomic DNA methylation changes in response to folic acid supplementation in a population-based intervention study among women of reproductive age. PLoS One 2011 0.90
73 Obstetrician-gynaecologist knowledge of and access to information about the risks of medication use during pregnancy. J Matern Fetal Neonatal Med 2010 0.90
74 Survival among people with Down syndrome: a nationwide population-based study in Denmark. Genet Med 2012 0.90
75 Non-genetic risk factors for holoprosencephaly. Am J Med Genet C Semin Med Genet 2010 0.89
76 Emerging and zoonotic infections in women. Infect Dis Clin North Am 2008 0.89
77 Craniosynostosis and nutrient intake during pregnancy. Birth Defects Res A Clin Mol Teratol 2010 0.88
78 Benefits of influenza vaccination during pregnancy for pregnant women. Am J Obstet Gynecol 2012 0.88
79 Methods for a public health response to birth defects clusters. Teratology 2002 0.88
80 Anthrax cases in pregnant and postpartum women: a systematic review. Obstet Gynecol 2012 0.88
81 Maternal bronchodilator use and the risk of orofacial clefts. Hum Reprod 2011 0.88
82 Craniosynostosis and maternal smoking. Birth Defects Res A Clin Mol Teratol 2008 0.88
83 Estimating Contraceptive Needs and Increasing Access to Contraception in Response to the Zika Virus Disease Outbreak - Puerto Rico, 2016. MMWR Morb Mortal Wkly Rep 2016 0.87
84 Maternal caffeine intake and risk of selected birth defects in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 2011 0.87
85 Research on vaccines during pregnancy: protocol design and assessment of safety. Vaccine 2013 0.87
86 Modeling the potential public health impact of prepregnancy obesity on adverse fetal and infant outcomes. Obesity (Silver Spring) 2013 0.87
87 Maternal thyroid disease, thyroid medication use, and selected birth defects in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 2009 0.87
88 Barriers to successful dietary control among pregnant women with phenylketonuria. Genet Med 2002 0.87
89 2009 pandemic influenza A (H1N1) virus infection in postpartum women in California. Am J Obstet Gynecol 2010 0.87
90 Assessment of risk factors for infantile cataracts using a case-control study: National Birth Defects Prevention Study, 2000-2004. Ophthalmology 2010 0.86
91 Research on vaccines during pregnancy: reference values for vital signs and laboratory assessments. Vaccine 2013 0.86
92 Ethical issues raised by incorporation of genetics into the National Birth Defects Prevention Study. Am J Med Genet C Semin Med Genet 2008 0.85
93 Understanding attitudes toward people with Down syndrome. Am J Med Genet A 2010 0.85
94 Down syndrome: national conference on patient registries, research databases, and biobanks. Mol Genet Metab 2011 0.85
95 Maternal exposure to tobacco smoke, alcohol and caffeine, and risk of anorectal atresia: National Birth Defects Prevention Study 1997-2003. Paediatr Perinat Epidemiol 2009 0.84
96 Trends and racial disparities in muscular dystrophy deaths in the United States, 1983-1998: an analysis of multiple cause mortality data. Am J Med Genet A 2006 0.84
97 Pharmacists' knowledge, attitudes, and practices regarding influenza vaccination and treatment of pregnant women. J Am Pharm Assoc (2003) 2012 0.84
98 Descriptive study of nonsyndromic atrioventricular septal defects in the National Birth Defects Prevention Study, 1997-2005. Am J Med Genet A 2011 0.84
99 Women's knowledge, attitudes, and beliefs about Down syndrome: a qualitative research study. Am J Med Genet A 2012 0.83
100 Trends in cytogenetic testing and identification of chromosomal abnormalities among pregnancies and children with birth defects, metropolitan Atlanta, 1968-2005. Am J Med Genet A 2011 0.82
101 Management of prescription and nonprescription drug use during pregnancy. J Matern Fetal Neonatal Med 2010 0.82
102 Pandemic influenza and pregnancy revisited: lessons learned from 2009 pandemic influenza A (H1N1). Am J Obstet Gynecol 2011 0.82
103 Prenatal diagnosis of orofacial clefts, National Birth Defects Prevention Study, 1998-2004. Prenat Diagn 2009 0.82
104 Hospitalizations among people with Down syndrome: a nationwide population-based study in Denmark. Am J Med Genet A 2013 0.81
105 The safety of adjuvants in influenza vaccines during pregnancy: what do we know and why do we need them? Am J Obstet Gynecol 2012 0.81
106 Maternal caffeine intake during pregnancy and orofacial clefts. Birth Defects Res A Clin Mol Teratol 2009 0.81
107 Frequency of prenatal cytogenetic diagnosis and pregnancy outcomes by maternal race-ethnicity, and the effect on the prevalence of trisomy 21, Metropolitan Atlanta, 1996-2005. Am J Med Genet A 2013 0.81
108 Maternal periconceptional exposure to cigarette smoking and alcohol consumption and congenital diaphragmatic hernia. Birth Defects Res A Clin Mol Teratol 2010 0.81
109 Epidemiology of fertility treatment use among U.S. women with liveborn infants, 1997-2004. J Womens Health (Larchmt) 2010 0.80
110 Birth defects and preterm birth: overlapping outcomes with a shared strategy for research and prevention. Birth Defects Res A Clin Mol Teratol 2009 0.79
111 Corticosteroid use and risk of orofacial clefts. Birth Defects Res A Clin Mol Teratol 2014 0.79
112 Developmental outcomes in young children born to mothers with West Nile illness during pregnancy. Birth Defects Res A Clin Mol Teratol 2014 0.79
113 Metabolic disorders detectable by tandem mass spectrometry and unexpected early childhood mortality: a population-based study. Am J Med Genet A 2006 0.79
114 Maternal smoking, xenobiotic metabolizing enzyme gene variants, and gastroschisis risk. Am J Med Genet A 2014 0.78
115 Maternal body mass index as a risk factor for craniosynostosis. Am J Med Genet A 2010 0.78
116 Understanding physicians' attitudes toward people with Down syndrome. Am J Med Genet A 2011 0.78
117 Letter to the editor: Ventricular septal defects and the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 2010 0.77
118 Prophylaxis and treatment of anthrax in pregnant women. Obstet Gynecol 2013 0.77
119 Addressing concerns of pregnant and lactating women after the 2005 hurricanes: the OTIS response. MCN Am J Matern Child Nurs 2008 0.77
120 Social conditions for people with Down syndrome: a register-based cohort study in Denmark. Am J Med Genet A 2013 0.77
121 Closure of varicella-zoster virus-containing vaccines pregnancy registry - United States, 2013. MMWR Morb Mortal Wkly Rep 2014 0.77
122 Clinical geneticists in birth defects surveillance and epidemiology research programs: past, present and future roles. Birth Defects Res A Clin Mol Teratol 2009 0.77
123 Epidemiology of twinning in the National Birth Defects Prevention Study, 1997 to 2007. Birth Defects Res A Clin Mol Teratol 2014 0.77
124 Highlights from the United States Food and Drug Administration's public workshop on the development of animal models of pregnancy to address medical countermeasures in an "at-risk" population of pregnant women: Influenza as a case study. Birth Defects Res A Clin Mol Teratol 2014 0.77
125 Pregnancy Outcomes After Maternal Zika Virus Infection During Pregnancy - U.S. Territories, January 1, 2016-April 25, 2017. MMWR Morb Mortal Wkly Rep 2017 0.77
126 A pilot study using residual newborn dried blood spots to assess the potential role of cytomegalovirus and Toxoplasma gondii in the etiology of congenital hydrocephalus. Birth Defects Res A Clin Mol Teratol 2013 0.76
127 Maternal and neonatal vitamin B12 deficiency detected through expanded newborn screening--United States, 2003-2007. J Pediatr 2010 0.76
128 Risks Associated With Smallpox Vaccination in Pregnancy: A Systematic Review and Meta-analysis. Obstet Gynecol 2015 0.75
129 Prepregnancy obesity and birth defects: what's next? Am J Clin Nutr 2010 0.75
130 Maternal mortality due to pandemic influenza A H1N1 2009 virus in Colombia. J Perinat Med 2014 0.75
131 Prenatal versus postnatal repair of myelomeningocele. N Engl J Med 2011 0.75
132 Hypomethylation of serum blood clot DNA, but not plasma EDTA-blood cell pellet DNA, from vitamin B12-deficient subjects. PLoS One 2013 0.75
133 Preventing Transmission of Zika Virus in Labor and Delivery Settings Through Implementation of Standard Precautions - United States, 2016. MMWR Morb Mortal Wkly Rep 2016 0.75
134 Prevalence and predictors of receipt of prenatal information about genetic screening. Prenat Diagn 2006 0.75
135 Personal Protective Equipment Supply Chain: Lessons Learned from Recent Public Health Emergency Responses. Health Secur 2017 0.75
136 Middle East Respiratory Syndrome (MERS). Microbiol Spectr 2016 0.75
137 Update: Interim Guidance for the Diagnosis, Evaluation, and Management of Infants with Possible Congenital Zika Virus Infection - United States, October 2017. MMWR Morb Mortal Wkly Rep 2017 0.75